Humana Inc. shares rose approximately 48% [1] over the past month, according to market data as of Monday, May 18.
The surge indicates a period of significant growth for the managed care provider relative to its competitors. This rapid ascent places the company in a strong position compared to other major healthcare stocks traded on the New York Stock Exchange.
Shares of Humana (NYSE:HUM) were trading near $303 [1] at midday Monday. This follows a period of steady growth throughout the previous month. For comparison, Humana stock rose 36% [5] in April 2026 and closed at $236.44 [6] on April 30.
Other industry leaders also saw gains during the same period. UnitedHealth Group stock rose 37% [3] in April 2026, closing the month at $370.48 [4] on April 30. While both companies experienced a bullish trend, Humana's more recent one-month trajectory has outpaced the growth seen in UnitedHealth and Cigna [1].
Market analysts said there is a disparity in these gains. The difference between the 36% rise in April [5] and the 48% gain over the most recent 30-day window suggests an accelerating trend in investor confidence for the company.
“Humana's stock price rose about 48% over the past month”
The rapid appreciation of Humana's share price relative to UnitedHealth and Cigna suggests a market correction or a specific investor pivot toward Humana's current valuation. While both Humana and UnitedHealth saw gains exceeding 30% in April, Humana's continued momentum into May indicates a sharper recovery or growth spike that separates it from the broader managed care sector.
